📊 NIMU Key Takeaways
Is NIMU a Good Investment? Thesis Analysis
NIMU is technically insolvent with negative stockholders equity of -$989K, virtually zero revenue ($6K), and massive operating losses exceeding 700% of revenue. The company burns cash with no operational profitability or liquidity to service its $2.1M debt burden, indicating imminent bankruptcy risk.
Why Buy NIMU? Key Strengths
- Company still operationally active in electromedical sector
- Some long-term debt indicates prior creditor confidence
- Minimal cash burn rate given scale ($22K annually)
NIMU Investment Risks to Consider
- Negative stockholders equity - company is balance sheet insolvent
- Insufficient liquidity - current ratio of 0.01x cannot meet obligations
- Revenue collapse with $6K annual revenue and zero growth momentum
- Debt burden of $2.1M long-term debt plus $995K liabilities vastly exceeds $6K in total assets
- Persistent negative operating cash flow with no path to profitability
- Zero insider activity suggests abandonment by management
Key Metrics to Watch
- Stockholders equity recovery (currently -$989K)
- Operating cash flow sustainability (currently -$22K)
- Debt restructuring or default events
- Revenue generation inflection (currently $6K, needs 100x+ growth)
NIMU Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NIMU Profitability Ratios
NIMU vs Healthcare Sector
How NON INVASIVE MONITORING SYSTEMS INC /FL/ compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NIMU Overvalued or Undervalued?
Based on fundamental analysis, NON INVASIVE MONITORING SYSTEMS INC /FL/ has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NIMU Balance Sheet & Liquidity
NIMU 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: NON INVASIVE MONITORING SYSTEMS INC /FL/'s revenue has declined by 94% over the 5-year period, indicating business contraction. The most recent EPS of $0.00 indicates the company is currently unprofitable.
NIMU Growth Metrics (YoY)
NIMU Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2018 | $6.0K | -$102.0K | N/A |
| Q2 2018 | $5.0K | -$99.0K | N/A |
| Q3 2017 | $6.0K | -$102.0K | N/A |
| Q2 2017 | $5.0K | -$111.0K | N/A |
| Q1 2017 | $8.0K | -$94.0K | N/A |
| Q3 2016 | $7.0K | -$85.0K | N/A |
| Q2 2016 | $8.0K | -$111.0K | N/A |
| Q1 2016 | N/A | -$94.0K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
NIMU Capital Allocation
NIMU SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for NON INVASIVE MONITORING SYSTEMS INC /FL/ (CIK: 0000720762)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NIMU
What is the AI rating for NIMU?
NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NIMU's key strengths?
Claude: Company still operationally active in electromedical sector. Some long-term debt indicates prior creditor confidence.
What are the risks of investing in NIMU?
Claude: Negative stockholders equity - company is balance sheet insolvent. Insufficient liquidity - current ratio of 0.01x cannot meet obligations.
What is NIMU's revenue and growth?
NON INVASIVE MONITORING SYSTEMS INC /FL/ reported revenue of $6.0K.
Does NIMU pay dividends?
NON INVASIVE MONITORING SYSTEMS INC /FL/ does not currently pay dividends.
Where can I find NIMU SEC filings?
Official SEC filings for NON INVASIVE MONITORING SYSTEMS INC /FL/ (CIK: 0000720762) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NIMU's EPS?
NON INVASIVE MONITORING SYSTEMS INC /FL/ has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NIMU a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, NON INVASIVE MONITORING SYSTEMS INC /FL/ has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NIMU stock overvalued or undervalued?
Valuation metrics for NIMU: ROE of N/A (sector avg: 15%), net margin of -700.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NIMU stock in 2026?
Our dual AI analysis gives NON INVASIVE MONITORING SYSTEMS INC /FL/ a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NIMU's free cash flow?
NON INVASIVE MONITORING SYSTEMS INC /FL/'s operating cash flow is $-22.0K, with capital expenditures of N/A. FCF margin is -366.7%.
How does NIMU compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -700.0% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.01 (avg: 2).